Literature DB >> 6475921

Genetic and environmental determinants of level of pulmonary function.

F I Lewitter, I B Tager, M McGue, P V Tishler, F E Speizer.   

Abstract

Measurements of level of pulmonary function (one second forced expiratory volume (FEV1) and forced expiratory flow between the 25% and 75% volume points (FEF 25-75)) were obtained on members of 404 nuclear families living in East Boston, Massachusetts in 1974. These families were ascertained through a random sample of children aged 5-9 years. Measurements were obtained on family members on three separate occasions during a 5-year period. These data were subjected to the techniques of path analysis to study the relative contributions of heredity and environment to individual levels of pulmonary function. Genetic heritability was found to be consistent through time (41-47%) and was the same for parents and their children. Common familial environmental effects on level of pulmonary function explained 1-4% of the variability in children and 11-28% in adults. Furthermore, we were able to confirm prior epidemiologic analysis of these data which have demonstrated an effect of maternal smoking on the level of pulmonary function in their children.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6475921     DOI: 10.1093/oxfordjournals.aje.a113912

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  21 in total

Review 1.  Genetics and pulmonary medicine.10: Genetic epidemiology of pulmonary function.

Authors:  Y Chen
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD.

Authors:  D L DeMeo; V J Carey; H A Chapman; J J Reilly; L C Ginns; F E Speizer; S T Weiss; E K Silverman
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

Review 3.  Progress in chronic obstructive pulmonary disease genetics.

Authors:  Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2006-07

4.  Secreted modular calcium-binding protein 2 haplotypes are associated with pulmonary function.

Authors:  Jemma B Wilk; Alan Herbert; Christina M Shoemaker; Daniel J Gottlieb; Samer Karamohamed
Journal:  Am J Respir Crit Care Med       Date:  2007-01-04       Impact factor: 21.405

Review 5.  Genetic inheritance effects on endurance and muscle strength: an update.

Authors:  Aldo M Costa; Luiza Breitenfeld; António J Silva; Ana Pereira; Mikel Izquierdo; Mário C Marques
Journal:  Sports Med       Date:  2012-06-01       Impact factor: 11.136

6.  The COPD genetic association compendium: a comprehensive online database of COPD genetic associations.

Authors:  Peter J Castaldi; Michael H Cho; Matthew Cohn; Fawn Langerman; Sienna Moran; Nestor Tarragona; Hala Moukhachen; Radhika Venugopal; Delvina Hasimja; Esther Kao; Byron Wallace; Craig P Hersh; Sachin Bagade; Lars Bertram; Edwin K Silverman; Thomas A Trikalinos
Journal:  Hum Mol Genet       Date:  2009-11-20       Impact factor: 6.150

7.  Vagal innervation is required for pulmonary function phenotype in Htr4-/- mice.

Authors:  John S House; Cody E Nichols; Huiling Li; Christina Brandenberger; Rohan S Virgincar; Laura M DeGraff; Bastiaan Driehuys; Darryl C Zeldin; Stephanie J London
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-27       Impact factor: 5.464

Review 8.  Genetic influences in sport and physical performance.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-10-01       Impact factor: 11.136

9.  Family history is a risk factor for COPD.

Authors:  Craig P Hersh; John E Hokanson; David A Lynch; George R Washko; Barry J Make; James D Crapo; Edwin K Silverman
Journal:  Chest       Date:  2011-02-10       Impact factor: 9.410

10.  Effects of physical activity on exercise tests and respiratory function.

Authors:  Y J Cheng; C A Macera; C L Addy; F S Sy; D Wieland; S N Blair
Journal:  Br J Sports Med       Date:  2003-12       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.